Semi-Annual Statement Of Cash Flows

D.Western Therapeutics Institute, Inc. - Filing #7612941

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-239,764,000 JPY
-159,711,000 JPY
-200,950,000 JPY
-289,527,000 JPY
Depreciation
45,259,000 JPY
44,157,000 JPY
Interest expenses
4,424,000 JPY
4,728,000 JPY
Foreign exchange losses (gains)
-17,822,000 JPY
6,950,000 JPY
Decrease (increase) in trade receivables
-9,796,000 JPY
11,645,000 JPY
Decrease (increase) in inventories
-30,075,000 JPY
1,044,000 JPY
Other, net
-23,425,000 JPY
-20,711,000 JPY
Subtotal
-170,652,000 JPY
-210,422,000 JPY
Interest and dividends received
21,000 JPY
130,000 JPY
Interest paid
-4,096,000 JPY
-4,404,000 JPY
Income taxes paid
-1,578,000 JPY
-1,588,000 JPY
Net cash provided by (used in) operating activities
-176,306,000 JPY
-216,284,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-2,314,000 JPY
-4,705,000 JPY
Purchase of investment securities
-109,148,000 JPY
-7,868,000 JPY
Net cash provided by (used in) investing activities
-111,150,000 JPY
-13,465,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
100,000,000 JPY
Repayments of long-term borrowings
-120,000,000 JPY
-120,000,000 JPY
Net cash provided by (used in) financing activities
-104,459,000 JPY
1,004,126,000 JPY
Effect of exchange rate change on cash and cash equivalents
17,449,000 JPY
-6,950,000 JPY
Net increase (decrease) in cash and cash equivalents
-374,466,000 JPY
767,425,000 JPY
Cash and cash equivalents
1,933,743,000 JPY
2,308,210,000 JPY
1,540,784,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.